The atypical PKC scaffold protein P62 is a novel target for anti-inflammatory and anti-cancer therapies
Year: 2002
Type: article
Source: Advances in Enzyme Regulation
Authors: Jorge Moscat, Marı́a T Diaz-Meco
Institution: Centro de Biología Molecular Severo Ochoa
Language: English
Topic: Bone Metabolism and Diseases
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1971962598